🚀 VC round data is live in beta, check it out!
Chemed Valuation Multiples
Discover revenue and EBITDA valuation multiples for Chemed and similar public comparables like Hinge Health, Brookdale Senior Living, Emeis, National Healthcare Corp and more.
Chemed Overview
About Chemed
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
Founded
1970
HQ
Employees
15.7K
Website
Sectors
Financials (LTM)
EV
$5B
Chemed Financials
Chemed reported last 12-month revenue of $3B and EBITDA of $468M.
In the same LTM period, Chemed generated $835M in gross profit, $468M in EBITDA, and $279M in net income.
Revenue (LTM)
Chemed P&L
In the most recent fiscal year, Chemed reported revenue of $3B and EBITDA of $459M.
Chemed expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | $835M | XXX | $823M | XXX | XXX | XXX |
| Gross Margin | 32% | XXX | 33% | XXX | XXX | XXX |
| EBITDA | $468M | XXX | $459M | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 18% | XXX | XXX | XXX |
| EBIT Margin | 16% | XXX | 16% | XXX | XXX | XXX |
| Net Profit | $279M | XXX | $265M | XXX | XXX | XXX |
| Net Margin | 11% | XXX | 10% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Chemed Stock Performance
Chemed has current market cap of $5B, and enterprise value of $5B.
Market Cap Evolution
Chemed's stock price is $384.61.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5B | $5B | 0.5% | XXX | XXX | XXX | $19.77 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialChemed Valuation Multiples
Chemed trades at 2.0x EV/Revenue multiple, and 11.2x EV/EBITDA.
EV / Revenue (LTM)
Chemed Financial Valuation Multiples
As of April 18, 2026, Chemed has market cap of $5B and EV of $5B.
Equity research analysts estimate Chemed's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Chemed has a P/E ratio of 18.5x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $5B | XXX | $5B | XXX | XXX | XXX |
| EV (current) | $5B | XXX | $5B | XXX | XXX | XXX |
| EV/Revenue | 2.0x | XXX | 2.1x | XXX | XXX | XXX |
| EV/EBITDA | 11.2x | XXX | 11.4x | XXX | XXX | XXX |
| EV/EBIT | 13.0x | XXX | 13.1x | XXX | XXX | XXX |
| EV/Gross Profit | 6.3x | XXX | 6.4x | XXX | XXX | XXX |
| P/E | 18.5x | XXX | 19.5x | XXX | XXX | XXX |
| EV/FCF | 16.2x | XXX | 16.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Chemed Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Chemed Margins & Growth Rates
Chemed's revenue in the last 12 month grew by 6%.
Chemed's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.
Chemed's rule of 40 is 24% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Chemed's rule of X is 32% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Chemed Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | 7% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 24% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 32% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| G&A Expenses to Revenue | 17% | XXX | 16% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 19% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Chemed Public Comps
See public comps and valuation multiples for other Long-Term Care comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Chemed | XXX | XXX | XXX | XXX | XXX | XXX |
| Hinge Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Brookdale Senior Living | XXX | XXX | XXX | XXX | XXX | XXX |
| Emeis | XXX | XXX | XXX | XXX | XXX | XXX |
| National Healthcare Corp | XXX | XXX | XXX | XXX | XXX | XXX |
| Extendicare | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Chemed M&A Activity
Chemed acquired XXX companies to date.
Last acquisition by Chemed was on XXXXXXXX, XXXXX. Chemed acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Chemed
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialChemed Investment Activity
Chemed invested in XXX companies to date.
Chemed made its latest investment on XXXXXXXX, XXXXX. Chemed invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Chemed
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Chemed
| When was Chemed founded? | Chemed was founded in 1970. |
| Where is Chemed headquartered? | Chemed is headquartered in United States. |
| How many employees does Chemed have? | As of today, Chemed has over 15K employees. |
| Who is the CEO of Chemed? | Chemed's CEO is Kevin J. Mcnamara. |
| Is Chemed publicly listed? | Yes, Chemed is a public company listed on NYSE. |
| What is the stock symbol of Chemed? | Chemed trades under CHE ticker. |
| When did Chemed go public? | Chemed went public in 1972. |
| Who are competitors of Chemed? | Chemed main competitors are Hinge Health, Brookdale Senior Living, Emeis, National Healthcare Corp. |
| What is the current market cap of Chemed? | Chemed's current market cap is $5B. |
| What is the current revenue of Chemed? | Chemed's last 12 months revenue is $3B. |
| What is the current revenue growth of Chemed? | Chemed revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Chemed? | Current revenue multiple of Chemed is 2.0x. |
| Is Chemed profitable? | Yes, Chemed is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Chemed? | Chemed's last 12 months EBITDA is $468M. |
| What is Chemed's EBITDA margin? | Chemed's last 12 months EBITDA margin is 18%. |
| What is the current EV/EBITDA multiple of Chemed? | Current EBITDA multiple of Chemed is 11.2x. |
| What is the current FCF of Chemed? | Chemed's last 12 months FCF is $323M. |
| What is Chemed's FCF margin? | Chemed's last 12 months FCF margin is 13%. |
| What is the current EV/FCF multiple of Chemed? | Current FCF multiple of Chemed is 16.2x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.